Lucid Genomics provides in-kind access to its genomic analysis platform for laboratories participating in global undiagnosed disease genomics program. By providing our platform in-kind, we hope to help reduce barriers to genomic diagnostics and support Genetic Alliance’s efforts to expand equitable access for patients with rare diseases.” — Uira Souto Melo, Co-Founder and CEO at […]
Countable Certified Service Providers are certified by Countable Labs for demonstrated expertise using Countable PCR technology to support studies of all sizes PALO ALTO, Calif. — Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, today announced its Countable Certified Service Provider (CSP) program. The Countable CSP […]
Pythia Biosciences and Lexogen recently announced a strategic partnership to empower researchers with deeper biological insights by combining Lexogen’s expertise in RNA sequencing and library preparation with Pythia’s multi-omics data curation and analytics capabilities. Through this collaboration, Pythia will offer Lexogen’s wet-lab capabilities via direct sales and as a core component of its newly launched expanded data ecosystem […]
Supporting ADLM’s focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics Showcasing Roche’s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901 INDIANAPOLIS — (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing […]
Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program clinical starts Includes headline Phase 1 monotherapy data for TLN-121 in relapsed or refractory lymphomas with overall response rate of 84%, complete response rate of 32% and no […]
Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026 Malarek succeeds Brad Moore, who will retire at the end of July following nearly a decade of distinguished service at Roche Antonio Vergara appointed Chief Commercial Officer to lead U.S. commercial business units INDIANAPOLIS […]
Adam Brown has been appointed Managing Director, assuming responsibility for the day-to-day leadership of the business As part of the transition, Richard Brown will become Chairman after 26 years as Managing Director, while John Clapham will continue supporting the company in his role as Founder. The changes reflect a planned succession process that combines continuity, […]
TriLink’s Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs SAN DIEGO — TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual […]
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company’s SYNTAX® platform across India. Under the agreement, ILS will distribute […]
New Juno Bio lab infrastructure marks a major step in scaling provider-led care and advancing precision vaginal microbiome testing OAKLAND, Calif. — Juno Bio, a women’s health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women’s […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
